Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate
Year: 2019
Type: article
Source: Supportive Care in Cancer
Institutions: National Institutes of Health, National Institutes of Health Clinical Center, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Center for Cancer Research, Center for Biologics Evaluation and Research, United States Food and Drug Administration, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2993474789
